|
1
|
Charafe-Jauffret E, Ginestier C, Monville
F, Finetti P, Adélaïde J, Cervera N, Fekairi S, Xerri L, Jacquemier
J, Birnbaum D, et al: Gene expression profiling of breast cell
lines identifies potential new basal markers. Oncogene.
25:2273–2284. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cheang MC, Voduc D, Bajdik C, Leung S,
McKinney S, Chia SK, Perou CM and Nielsen TO: Basal-like breast
cancer defined by five biomarkers has superior prognostic value
than triple-negative phenotype. Clin Cancer Res. 14:1368–1376.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Langbein L, Rogers MA, Winter H, Praetzel
S and Schweizer J: The catalog of human hair keratins. II.
Expression of the six type II members in the hair follicle and the
combined catalog of human type I and II keratins. J Biol Chem.
276:35123–35132. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Langbein L and Schweizer J: Keratins of
the human hair follicle. Int Rev Cytol. 243:1–78. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Boulay A, Régnier CH, Anglard P, Stoll I,
Tomasetto C and Rio MC: Transcription regulation and protein
subcellular localization of the truncated basic hair keratin
hHb1-DeltaN in human breast cancer cells. J Biol Chem.
276:22954–22964. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Régnier CH, Boulay A, Asch PH, Wendling C,
Chenard MP, Tomasetto C and Rio MC: Expression of a truncated form
of hHb1 hair keratin in human breast carcinomas. Br J Cancer.
78:1640–1644. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tomasetto C, Régnier C, Moog-Lutz C,
Mattei MG, Chenard MP, Lidereau R, Basset P and Rio MC:
Identification of four novel human genes amplified and
overexpressed in breast carcinoma and localized to the q11-q21.3
region of chromosome 17. Genomics. 28:367–376. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Figueira RC, Gomes LR, Neto JS, Silva FC,
Silva ID and Sogayar MC: Correlation between MMPs and their
inhibitors in breast cancer tumor tissue specimens and in cell
lines with different metastatic potential. BMC Cancer. 9:202009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ren F, Tang R, Zhang X, Madushi WM, Luo D,
Dang Y, Li Z, Wei K and Chen G: Overexpression of MMP family
members functions as prognostic biomarker for breast cancer
patients: A systematic review and meta-analysis. PLoS One.
10:e01355442015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nanashima N, Akita M, Yamada T, Shimizu T,
Nakano H, Fan Y and Tsuchida S: The hairless phenotype of the
Hirosaki hairless rat is due to the deletion of an 80-kb genomic
DNA containing five basic keratin genes. J Biol Chem.
283:16868–16875. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nanashima N, Asano J, Hayakari M, Nakamura
T, Nakano H, Yamada T, Shimizu T, Akita M, Fan Y and Tsuchida S:
Nuclear localization of STAT5A modified with O-linked
N-acetylglucosamine and early involution in the mammary
gland of Hirosaki hairless rat. J Biol Chem. 280:43010–43016. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nanashima N, Yamada T, Shimizu T and
Tsuchida S: Deletion of phospholipase A2 group IVc
induces apoptosis in rat mammary tumour cells by the nuclear
factor-κB/lipocalin 2 pathway. Biochem J. 469:315–324. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
James V, Kearsley J, Irving T, Amemiya Y
and Cookson D: Using hair to screen for breast cancer. Nature.
398:33–34. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Corino GL and French PW: Diagnosis of
breast cancer by X-ray diffraction of hair. Int J Cancer.
122:847–856. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Corino GL, French PW, Lee M, Ajaj MM,
Haklani J, Mistry DA, Phan K and Yuile PG: Characterization of a
test for invasive breast cancer using X-ray diffraction of
hair-results of a clinical trial. Breast Cancer. 3:83–90.
2009.PubMed/NCBI
|
|
16
|
Cailleau R, Young R, Olivé M and Reeves WJ
Jr: Breast tumor cell lines from pleural effusions. J Natl Cancer
Inst. 53:661–674. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Towbin H, Staehelin T and Gordon J:
Electrophoretic transfer of proteins from polyacrylamide gels to
nitrocellulose sheets: Procedure and some applications. Proc Natl
Acad Sci USA. 76:4350–4354. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Laemmli UK: Cleavage of structural
proteins during the assembly of the head of bacteriophage T4.
Nature. 227:680–685. 1970. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Miyazaki K, Hattori Y, Umenishi F,
Yasumitsu H and Umeda M: Purification and characterization of
extracellular matrix-degrading metalloproteinase, matrin (pump-1),
secreted from human rectal carcinoma cell line. Cancer Res.
50:7758–7764. 1990.PubMed/NCBI
|
|
20
|
Umenishi F, Yasumitsu H, Ashida Y, Yamauti
J, Umeda M and Miyazaki K: Purification and properties of
extracellular matrix-degrading metallo-proteinase overproduced by
Rous sarcoma virus-transformed rat liver cell line, and its
identification as transin. J Biochem. 108:537–543. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Michno K, Boras-Granic K, Mill P, Hui CC
and Hamel PA: Shh expression is required for embryonic hair
follicle but not mammary gland development. Dev Biol. 264:153–165.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mikkola ML and Millar SE: The mammary bud
as a skin appendage: Unique and shared aspects of development. J
Mammary Gland Biol Neoplasia. 11:187–203. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Escobar-Hoyos LF, Shah R, Roa-Peña L,
Vanner EA, Najafian N, Banach A, Nielsen E, Al-Khalil R, Akalin A,
Talmage D, et al: Keratin-17 promotes p27KIP1 nuclear
export and degradation and offers potential prognostic utility.
Cancer Res. 75:3650–3662. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hobbs RP, Jacob JT and Coulombe PA:
Keratins are going nuclear. Dev Cell. 38:227–233. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nishikawa J, Kiss C, Imai S, Takada K,
Okita K, Klein G and Szekely L: Upregulation of the truncated basic
hair keratin 1(hHb1-DeltaN) in carcinoma cells by Epstein-Barr
virus (EBV). Int J Cancer. 107:597–602. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang J, Bielenberg DR, Rodig SJ, Doiron R,
Clifton MC, Kung AL, Strong RK, Zurakowski D and Moses MA:
Lipocalin 2 promotes breast cancer progression. Proc Natl Acad Sci
USA. 106:3913–3918. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kang H, Lee M, Choi KC, Shin DM, Ko J and
Jang SW: N-(4-hydroxyphenyl)retinamide inhibits breast
cancer cell invasion through suppressing NF-KB activation and
inhibiting matrix metalloproteinase-9 expression. J Cell Biochem.
113:2845–2855. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li SH, Hawthorne VS, Neal CL, Sanghera S,
Xu J, Yang J, Guo H, Steeg PS and Yu D: Upregulation of neutrophil
gelatinase-associated lipocalin by ErbB2 through nuclear
factor-kappaB activation. Cancer Res. 69:9163–9168. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Arena A, Stassi G, Iannello D, Gazzara D,
Calapai M, Bisignano C, Bolignano D, Lacquaniti A and Buemi M: Both
IL-1β and TNF-α regulate NGAL expression in
polymorphonuclear granulocytes of chronic hemodialysis patients.
Mediators Inflamm. 2010:6139372010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee SJ, Park SS, Cho YH, Park K, Kim EJ,
Jung KH, Kim SK, Kim WJ and Moon SK: Activation of matrix
metalloproteinase-9 by TNF-α in human urinary bladder cancer HT1376
cells: The role of MAP kinase signaling pathways. Oncol Rep.
19:1007–1013. 2008.PubMed/NCBI
|
|
31
|
Moon SK, Cha BY and Kim CH: ERK1/2
mediates TNF-alpha-induced matrix metalloproteinase-9 expression in
human vascular smooth muscle cells via the regulation of NF-kappaB
and AP-1: Involvement of the ras dependent pathway. J Cell Physiol.
198:417–427. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zer C, Sachs G and Shin JM: Identification
of genomic targets downstream of p38 mitogen-activated protein
kinase pathway mediating tumor necrosis factor-alpha signaling.
Physiol Genomics. 31:343–351. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Banno T, Gazel A and Blumenberg M: Effects
of tumor necrosis factor-alpha (TNF alpha) in epidermal
keratinocytes revealed using global transcriptional profiling. J
Biol Chem. 279:32633–32642. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yoo KH and Hennighausen L: EZH2
methyltransferase and H3K27 methylation in breast cancer. Int J
Biol Sci. 8:59–65. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Italiano A: Role of the EZH2 histone
methyltransferase as a therapeutic target in cancer. Pharmacol
Ther. 165:26–31. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kim KH and Roberts CW: Targeting EZH2 in
cancer. Nat Med. 22:128–134. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lee ST, Li Z, Wu Z, Aau M, Guan P,
Karuturi RK, Liou YC and Yu Q: Context-specific regulation of NF-κB
target gene expression by EZH2 in breast cancers. Mol Cell.
43:798–810. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nakata B, Takashima T, Ogawa Y, Ishikawa T
and Hirakawa K: Serum CYFRA 21–1 (cytokeratin-19 fragments) is a
useful tumour marker for detecting disease relapse and assessing
treatment efficacy in breast cancer. Br J Cancer. 91:873–878.
2004.PubMed/NCBI
|
|
39
|
Uenishi T, Kubo S, Hirohashi K, Tanaka H,
Shuto T, Yamamoto T and Nishiguchi S: Cytokeratin-19 fragments in
serum (CYFRA 21–1) as a marker in primary liver cancer. Br J
Cancer. 88:1894–1899. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Campayo M, Navarro A, Viñolas N, Tejero R,
Muñoz C, Diaz T, Marrades R, Cabanas ML, Gimferrer JM, Gascon P, et
al: A dual role for KRT81: A miR-SNP associated with recurrence in
non-small-cell lung cancer and a novel marker of squamous cell lung
carcinoma. PLoS One. 6:e225092011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lee SY, Choi JE, Jeon HS, Hong MJ, Choi
YY, Kang HG, Yoo SS, Lee EB, Jeong JY, Lee WK, et al: A genetic
variation in microRNA target site of KRT81 gene is
associated with survival in early-stage non-small-cell lung cancer.
Ann Oncol. 26:1142–1148. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Robles AI and Ryan BM: KRT81
miR-SNP rs3660 is associated with risk and survival of NSCLC. Ann
Oncol. 27:360–361. 2016. View Article : Google Scholar : PubMed/NCBI
|
